Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1999-8-11
pubmed:abstractText
The CFTR chloride channel is regulated by phosphorylation by protein kinases, especially PKA, and by nucleotides interacting with the two nucleotide binding domains, NBD-A and NBD-B. Giant excised inside-out membrane patches from Xenopus oocytes expressing human epithelial cystic fibrosis transmembrane conductance regulator (CFTR) were tested for their chloride conductance in response to the application of PKA and nucleotides. Rapid changes in the concentration of ATP, its nonhydrolyzable analogue adenylylimidodiphosphate (AMP-PNP), its photolabile derivative ATP-P3-[1-(2-nitrophenyl)ethyl]ester, or ADP led to changes in chloride conductance with characteristic time constants, which reflected interaction of CFTR with these nucleotides. The conductance changes of strongly phosphorylated channels were slower than those of partially phosphorylated CFTR. AMP-PNP decelerated relaxations of conductance increase and decay, whereas ATP-P3-[1-(2-nitrophenyl)ethyl]ester only decelerated the conductance increase upon ATP addition. ADP decelerated the conductance increase upon ATP addition and accelerated the conductance decay upon ATP withdrawal. The results present the first direct evidence that AMP-PNP binds to two sites on the CFTR. The effects of ADP also suggest two different binding sites because of the two different modes of inhibition observed: it competes with ATP for binding (to NBD-A) on the closed channel, but it also binds to channels opened by ATP, which might either reflect binding to NBD-A (i.e., product inhibition in the hydrolysis cycle) or allosteric binding to NBD-B, which accelerates the hydrolysis cycle at NBD-A.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-10102935, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-10398691, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-1279436, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-1279437, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-1371239, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-1382316, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-148906, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-1714039, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-1717461, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-1718606, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-1719758, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-1973824, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-2147378, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-2475911, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-6089180, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-6823316, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-6938971, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-7512348, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-7515176, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-7518455, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-7520292, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-7530246, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-7539480, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-7539989, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-7543023, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-7682009, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-7687643, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-8549739, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-8661489, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-8760028, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-8913588, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-9441944, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-9558482, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-9569250, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-9642211, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-9684873, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-9922377, http://linkedlifedata.com/resource/pubmed/commentcorrection/10398692-9931011
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0022-1295
pubmed:author
pubmed:issnType
Print
pubmed:volume
114
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
55-70
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1999
pubmed:articleTitle
Dual effects of ADP and adenylylimidodiphosphate on CFTR channel kinetics show binding to two different nucleotide binding sites.
pubmed:affiliation
Max-Planck-Institut für Biophysik, 60596 Frankfurt/M., Germany.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't